Moderna Seeks FDA Nod for Booster Shot Aimed at Omicron BA.4, BA.5

Moderna Inc MRNA.O said on Tuesday it has completed its submission to the U.S. Food and Drug Administration for the emergency use authorization of its COVID-19 booster shot tailored against the BA.4 and BA.5 subvariants of Omicron. Great!

Read more about it

Photo Credit: Mufid Majnun